查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1866525

全球微生物附著量檢測市場－2025-2030年預測

Global Bioburden Testing Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

微生物附著量檢測市場預計將從 2025 年的 17.73 億美元成長到 2030 年的 34.53 億美元，複合年成長率為 14.27%。

微生物附著量測試，也稱為微生物計數 (MET)，用於量化醫療設備和藥品上的活微生物數量，​​從而確保產品安全。此測試透過測量微生物數量來確定醫療設備的最佳滅菌參數，這是確保符合嚴格監管標準的關鍵步驟。

受製藥和醫療設備產業持續擴張以及監管要求日益嚴格的推動，微生物附著量檢測市場預計將迎來顯著成長。然而，檢測設備的高成本和冗長的核准流程可能會在預測期內阻礙市場擴張。

本研究檢驗了目前微生物附著量市場發展的最新動態。研究全面分析了關鍵促進因素、限制因素和機遇，並深入剖析了不同地區的行業趨勢、政策和法規，使相關人員能夠深入了解法律規範和影響市場環境的因素。

我們的競爭情報是基於廣泛的二手資料研究，旨在識別關鍵產業參與者及其收入貢獻。資訊來源包括產業協會調查、分析師報告、投資者報告、新聞稿和學術期刊。我們採用自下而上和自上而下的方法計算了微生物附著量檢測市場及其主要細分市場的整體市場規模。相關數據已透過全球微生物附著量檢測價值鏈相關人員的第一手資訊進行檢驗。我們全面的市場分析整合了多種資訊來源和專有資料集，並運用資料三角驗證法，以提供準確的市場區隔和預測。

報告透過分析說明、圖表和圖形呈現市場洞察，以便有效了解全球微生物附著量檢測市場的動態。主要企業簡介包括SGS SA、賽默飛世爾科技和貝克頓·迪金森公司。

本報告為業內專業人士提供關於市場趨勢、法規環境和競爭動態的關鍵洞察。報告重點闡述了產業擴張和合規需求帶來的成長機遇，同時也探討了高成本和冗長的核准流程等挑戰。嚴謹的調查方法，結合一手和二手數據，確保了報告內容的可靠性。本報告能夠幫助相關人員應對監管的複雜性、競爭壓力和投資重點，從而保障醫療器材和藥品的安全性和有效性。

本報告的主要優勢：

  • 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
  • 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
  • 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
  • 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2022-2024 年）和預測資料（2025-2030 年）
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區（國家）分類的收入成長和預測分析
  • 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

5. 全球微生物附著量檢測市場（依產品分類）

  • 介紹
  • 消耗品
    • 培養基
    • 試劑盒和試劑
    • 其他
  • 裝置
    • PCR裝置
    • 顯微鏡
    • 流式細胞儀
    • 自動微生物鑑定系統
  • 軟體和服務

6. 全球微生物附著量檢測市場（依應用分類）

  • 介紹
  • 原料測試
  • 醫療設備測試
  • 進程內測試
  • 環境監測

7. 全球微生物附著量檢測市場（依最終用戶分類）

  • 介紹
  • 製藥和生物技術製造商
  • CMO（委外研發機構）
  • 醫療設備製造商
  • 其他

8. 全球微生物附著量檢測市場（按地區分類）

  • 介紹
  • 北美洲
    • 依產品
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依產品
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 依產品
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 英國
      • 德國
      • 法國
      • 義大利
      • 其他
  • 中東和非洲
    • 依產品
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 依產品
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 台灣
      • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第10章：公司簡介

  • Merck KGaA
  • Pacific BioLabs Inc.
  • Mettler Toledo International Inc.
  • Charles River Laboratories, Inc.
  • Rapid Micro Biosystems, Inc.
  • Thermo Fisher Scientific
  • WuXi AppTec
  • Becton, Dickinson, and Company
  • SGS SA
  • Nelson Laboratories, LLC
  • bioMerieuxx SA

第11章 分析方法

簡介目錄
Product Code: KSI061611930

The Bioburden Testing Market is expected to soar from USD 1.773 billion in 2025 to USD 3.453 billion in 2030, at a CAGR of 14.27%.

Bioburden testing, also known as microbial enumeration testing (MET), quantifies viable microorganisms on medical devices or pharmaceutical ingredients, ensuring product safety for manufacturers. This testing determines microbial counts to establish optimal sterilization parameters for medical devices, a critical step in maintaining compliance with stringent regulatory standards.

The bioburden testing market is poised for significant growth, driven by the expanding pharmaceutical and medical device industries and rigorous regulatory requirements. However, high costs of testing instruments and prolonged approval processes may impede market expansion during the forecast period.

This research examines current trends in demand, supply, and sales, alongside recent developments shaping the bioburden testing market. It provides a comprehensive analysis of key drivers, restraints, and opportunities. The study details industry trends, policies, and regulations across geographical regions, offering stakeholders a thorough understanding of the regulatory framework and factors influencing the market environment.

Competitive intelligence identifies major industry players and their revenue contributions, derived from extensive secondary research. Sources include industry association studies, analyst reports, investor presentations, press releases, and journals. Market size for the overall bioburden testing sector and its key segments was determined using both bottom-up and top-down methodologies. Values were validated with primary inputs from stakeholders in the global bioburden testing value chain. Comprehensive market engineering integrated data from diverse sources and proprietary datasets, employing data triangulation for accurate market breakdown and forecasting.

Market insights are presented through analytical narratives, charts, and graphics, enabling efficient comprehension of global bioburden testing market dynamics. Key players profiled include SGS SA, Thermo Fisher Scientific, and Becton, Dickinson, and Company, among others.

This report equips industry experts with critical insights into market trends, regulatory landscapes, and competitive dynamics. It highlights growth opportunities driven by industry expansion and compliance needs while addressing challenges such as high instrument costs and lengthy approval timelines. The rigorous methodology, blending primary and secondary data, ensures reliable findings, enabling stakeholders to navigate regulatory complexities, competitive pressures, and investment priorities in a market vital to ensuring the safety and efficacy of medical devices and pharmaceuticals.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Products

  • Consumables
  • Culture Media
  • Kits and Reagents
  • Others
  • Instruments
  • PCR Equipment
  • Microscopes
  • Flow cytometers
  • Automated microbial identification systems
  • Software & Services

By Application

  • Raw Material Testing
  • Medical Devices Testing
  • In-Process Testing
  • Environmental Monitoring

By End-User

  • Pharmaceuticals and Biotechnology Manufacturers
  • CMOs
  • Medical Device Manufacturers
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BIOBURDEN TESTING MARKET BY PRODUCTS

  • 5.1. Introduction
  • 5.2. Consumables
    • 5.2.1. Culture Media
    • 5.2.2. Kits and Reagents
    • 5.2.3. Others
  • 5.3. Instruments
    • 5.3.1. PCR Equipment
    • 5.3.2. Microscopes
    • 5.3.3. Flow cytometers
    • 5.3.4. Automated microbial identification systems
  • 5.4. Software & Services

6. BIOBURDEN TESTING MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Raw Material Testing
  • 6.3. Medical Devices Testing
  • 6.4. In-Process Testing
  • 6.5. Environmental Monitoring

7. BIOBURDEN TESTING MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Pharmaceuticals and Biotechnology Manufacturers
  • 7.3. CMOs
  • 7.4. Medical Device Manufacturers
  • 7.5. Others

8. BIOBURDEN TESTING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Products
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Products
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Products
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Italy
      • 8.4.4.5. Others
  • 8.5. Middle East & Africa
    • 8.5.1. By Products
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Products
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Merck KGaA
  • 10.2. Pacific BioLabs Inc.
  • 10.3. Mettler Toledo International Inc.
  • 10.4. Charles River Laboratories, Inc.
  • 10.5. Rapid Micro Biosystems, Inc.
  • 10.6. Thermo Fisher Scientific
  • 10.7. WuXi AppTec
  • 10.8. Becton, Dickinson, and Company
  • 10.9. SGS SA
  • 10.10. Nelson Laboratories, LLC
  • 10.11. bioMerieuxx SA

11. RESEARCH METHODOLOGY